Amgen (AMGN)
351.58
+5.98 (1.73%)
Upcoming Events
Latest Headlines
AMGEN TO PRESENT AT THE GOLDMAN SACHS 47TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
June 4, 2026 4:01 PM - PR NewsWire
AMGEN presents data on rare disease drugs at european medical congress
June 3, 2026 9:01 AM - StreetInsider
AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026
June 3, 2026 9:00 AM - PR NewsWire
AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE
May 29, 2026 4:01 PM - PR NewsWire
Ember LifeSciences announces new strategic investments boosting Series A to $27M
May 27, 2026 9:00 AM - PR NewsWire
Form 4 AMGEN INC For: May 19 Filed by: MILES AMY E
May 21, 2026 7:08 PM - SEC Filing
Form 4 AMGEN INC For: May 19 Filed by: Kullman Ellen Jamison
May 21, 2026 7:07 PM - SEC Filing
Form 4 AMGEN INC For: May 19 Filed by: Klotman Mary E.
May 21, 2026 7:06 PM - SEC Filing
Form 4 AMGEN INC For: May 19 Filed by: Jacks Tyler
May 21, 2026 7:04 PM - SEC Filing
Form 4 AMGEN INC For: May 19 Filed by: ISHRAK OMAR
May 21, 2026 7:03 PM - SEC Filing
Form 4 AMGEN INC For: May 19 Filed by: HOLLEY CHARLES M
May 21, 2026 7:02 PM - SEC Filing
Form 4 AMGEN INC For: May 19 Filed by: Garland Greg C.
May 21, 2026 7:00 PM - SEC Filing
Form 4 AMGEN INC For: May 19 Filed by: ECKERT ROBERT
May 21, 2026 6:58 PM - SEC Filing
Form 4 AMGEN INC For: May 19 Filed by: Druker Brian
May 21, 2026 6:57 PM - SEC Filing
Form 4 AMGEN INC For: May 19 Filed by: Drake Michael V
May 21, 2026 6:56 PM - SEC Filing
Form 4 AMGEN INC For: May 19 Filed by: Austin Wanda M
May 21, 2026 6:54 PM - SEC Filing
Form 8-K AMGEN INC For: May 19
May 20, 2026 5:00 PM - SEC Filing
Form 8-K AMGEN INC For: May 19
May 19, 2026 4:08 PM - SEC Filing
AMGEN names Thomas Dittrich as new CFO as Peter Griffith retires
May 19, 2026 4:05 PM - StreetInsider
AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH
May 19, 2026 4:05 PM - PR NewsWire
Kissei Pharmaceutical warns against new TAVNEOS prescriptions amid safety concerns
May 15, 2026 3:43 PM - StreetInsider
Form SCHEDULE 13G AMGEN INC Filed by: Capital World Investors
May 14, 2026 1:57 PM - SEC Filing
Amgen (AMGN) PT Lowered to $427 at Piper Sandler
May 14, 2026 7:30 AM - StreetInsider
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
May 13, 2026 8:30 AM - Globe NewsWire
Form 4 AMGEN INC For: May 07 Filed by: Busch Matthew C.
May 11, 2026 8:18 PM - SEC Filing
Form 4 AMGEN INC For: May 07 Filed by: Santos Esteban
May 11, 2026 8:15 PM - SEC Filing
Form 4 AMGEN INC For: May 07 Filed by: REESE DAVID M
May 11, 2026 8:08 PM - SEC Filing
Form 4 AMGEN INC For: May 07 Filed by: Miller Derek
May 11, 2026 8:06 PM - SEC Filing
Form 4 AMGEN INC For: May 07 Filed by: Khosla Rachna
May 11, 2026 8:05 PM - SEC Filing
Form 4 AMGEN INC For: May 07 Filed by: Grygiel Nancy A.
May 11, 2026 8:03 PM - SEC Filing
Form 4 AMGEN INC For: May 07 Filed by: Griffith Peter H.
May 11, 2026 8:02 PM - SEC Filing
Form 4 AMGEN INC For: May 07 Filed by: Graham Jonathan P
May 11, 2026 8:00 PM - SEC Filing
Form 4 AMGEN INC For: May 07 Filed by: Gordon Murdo
May 11, 2026 7:58 PM - SEC Filing
Form 4 AMGEN INC For: May 07 Filed by: Bradway Robert A
May 11, 2026 7:39 PM - SEC Filing
Form 4 AMGEN INC For: May 07 Filed by: Bradner James E.
May 11, 2026 7:37 PM - SEC Filing
The Next Generation of the GLP-1 Revolution Is Already Underway
May 11, 2026 8:30 AM - Globe NewsWire
Form 4 AMGEN INC For: May 05 Filed by: Bradway Robert A
May 7, 2026 9:15 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: Bradner James E.
May 7, 2026 9:14 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: Busch Matthew C.
May 7, 2026 9:06 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: Gordon Murdo
May 7, 2026 9:02 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: Graham Jonathan P
May 7, 2026 9:00 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: Griffith Peter H.
May 7, 2026 8:57 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: Grygiel Nancy A.
May 7, 2026 8:54 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: Khosla Rachna
May 7, 2026 8:53 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: Miller Derek
May 7, 2026 8:51 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: REESE DAVID M
May 7, 2026 8:49 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: Santos Esteban
May 7, 2026 8:46 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: ISHRAK OMAR
May 7, 2026 8:41 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: HOLLEY CHARLES M
May 7, 2026 8:39 PM - SEC Filing
Form 4 AMGEN INC For: May 05 Filed by: Drake Michael V
May 7, 2026 8:36 PM - SEC Filing
AMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
May 7, 2026 4:01 PM - PR NewsWire
Freedom Broker Upgrades Amgen (AMGN) to Buy
May 7, 2026 8:28 AM - StreetInsider
Form 4 AMGEN INC For: May 02 Filed by: Santos Esteban
May 5, 2026 8:14 PM - SEC Filing
Form 4 AMGEN INC For: May 02 Filed by: REESE DAVID M
May 5, 2026 8:13 PM - SEC Filing
Form 4 AMGEN INC For: May 02 Filed by: Miller Derek
May 5, 2026 8:12 PM - SEC Filing
Form 4 AMGEN INC For: May 02 Filed by: Khosla Rachna
May 5, 2026 8:11 PM - SEC Filing
Form 4 AMGEN INC For: May 02 Filed by: Grygiel Nancy A.
May 5, 2026 8:10 PM - SEC Filing
Form 4 AMGEN INC For: May 02 Filed by: Griffith Peter H.
May 5, 2026 8:09 PM - SEC Filing
Form 4 AMGEN INC For: May 02 Filed by: Graham Jonathan P
May 5, 2026 8:08 PM - SEC Filing
Form 4 AMGEN INC For: May 02 Filed by: Gordon Murdo
May 5, 2026 8:07 PM - SEC Filing
Form 4 AMGEN INC For: May 02 Filed by: Busch Matthew C.
May 5, 2026 8:06 PM - SEC Filing
Form 4 AMGEN INC For: May 02 Filed by: Bradway Robert A
May 5, 2026 7:53 PM - SEC Filing
Erste Group Downgrades Amgen (AMGN) to Hold
May 5, 2026 6:13 AM - StreetInsider
Form 144 AMGEN INC Filed by: Grygiel Nancy A.
May 4, 2026 4:06 PM - SEC Filing
AMGEN announces $300 million US manufacturing investment
May 4, 2026 9:01 AM - StreetInsider
AMGEN ANNOUNCES ADDITIONAL $300 MILLION U.S. MANUFACTURING INVESTMENT, TOTALING NEARLY $2 BILLION OVER THE LAST YEAR
May 4, 2026 9:00 AM - PR NewsWire
Amgen (AMGN) PT Lowered to $340 at Guggenheim
May 4, 2026 6:45 AM - StreetInsider
Form 10-Q AMGEN INC For: Mar 31
May 1, 2026 9:44 AM - SEC Filing
Amgen (AMGN) PT Raised to $332 at Morgan Stanley
May 1, 2026 9:13 AM - StreetInsider
Amgen (AMGN) PT Raised to $327 at Truist Securities
May 1, 2026 7:11 AM - StreetInsider
Amgen (AMGN) PT Raised to $307 at BofA Securities
May 1, 2026 5:59 AM - StreetInsider
/C O R R E C T I O N -- Amgen/
April 30, 2026 7:03 PM - PR NewsWire
Form 8-K AMGEN INC For: Apr 30
April 30, 2026 4:05 PM - SEC Filing
Amgen (AMGN) Tops Q1 EPS by 35c, Offers Guidance
April 30, 2026 4:03 PM - StreetInsider
AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
April 30, 2026 4:01 PM - PR NewsWire
Amgen (AMGN) call put ratio 1.5 calls to 1 put with a focus on May 365 calls into quarter results
April 30, 2026 3:30 AM - StreetInsider
Form SCHEDULE 13G AMGEN INC Filed by: VANGUARD CAPITAL MANAGEMENT LLC
April 29, 2026 4:40 PM - SEC Filing
Amgen (AMGN) call put ratio 1.6 calls to 1 put into quarter results
April 29, 2026 11:23 AM - StreetInsider
AstraZeneca, Amgen partner with FDA to test real-time AI trial monitoring
April 28, 2026 1:46 PM - StreetInsider
AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS
April 24, 2026 4:01 PM - PR NewsWire
Form 8-K AMGEN INC For: Apr 22
April 22, 2026 4:03 PM - SEC Filing
AMGEN announces CTO David Reese retirement and leadership changes
April 22, 2026 4:00 PM - StreetInsider
AMGEN ANNOUNCES RETIREMENT OF DAVID M. REESE, EXECUTIVE VICE PRESIDENT AND CHIEF TECHNOLOGY OFFICER
April 22, 2026 4:00 PM - PR NewsWire
Form DEFA14A AMGEN INC
April 21, 2026 5:01 PM - SEC Filing
Canaccord Starts Amgen (AMGN) at Hold
April 20, 2026 4:12 PM - StreetInsider
Form DEFA14A AMGEN INC
April 15, 2026 4:16 PM - SEC Filing
Amgen (AMGN) PT Raised to $400 at UBS
April 13, 2026 8:53 AM - StreetInsider
Amgen (AMGN) PT Raised to $326 at Morgan Stanley
April 10, 2026 8:15 AM - StreetInsider
Amgen (AMGN) PT Raised to $351 at Guggenheim
April 9, 2026 7:08 AM - StreetInsider
Amgen (AMGN) Reiterated at Neutral by Cantor Fitzgerald Amid Negative/Neutral Sentiment
April 8, 2026 7:41 AM - StreetInsider
Amgen (AMGN) PT Raised to $325 at Truist Securities
April 8, 2026 6:06 AM - StreetInsider
Form DEFA14A AMGEN INC
April 7, 2026 4:26 PM - SEC Filing
Form DEF 14A AMGEN INC For: May 19
April 7, 2026 4:23 PM - SEC Filing
Amgen (AMGN) PT Raised to $370 at RBC Capital
April 7, 2026 9:03 AM - StreetInsider
William Blair on Amgen (AMGN): top-line results show 'strong efficacy' compared to VRDN data
April 6, 2026 12:41 PM - StreetInsider
Stifel on Viridian (VRDN): 'We view positive REVEAL-2 chronic TED data in 2Q26 as important'
April 6, 2026 9:46 AM - StreetInsider
N/a
April 6, 2026 9:00 AM - StreetInsider
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE
April 6, 2026 9:00 AM - PR NewsWire
RBC Capital: 'Amgen (AMGN) Highlights Key Growth Drivers For The Rest Of 2026 And Beyond'
April 2, 2026 8:07 AM - StreetInsider
Zai Lab partners with Amgen for combination cancer therapy trial
April 1, 2026 7:30 AM - StreetInsider
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy
April 1, 2026 7:30 AM - BizWire
Amgen’s Tavneos Tied to Deaths, Liver Injury - FDA
March 31, 2026 3:13 PM - StreetInsider
Form ARS AMGEN INC For: Dec 31
March 31, 2026 9:03 AM - SEC Filing
Jefferies on Amgen (AMGN): Elegrobart data not a 'significant competitive threat to Tepezza'
March 30, 2026 4:38 PM - StreetInsider
REPATHA® CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
March 28, 2026 4:45 PM - PR NewsWire
Form SCHEDULE 13G/A AMGEN INC Filed by: VANGUARD GROUP INC
March 26, 2026 3:43 PM - SEC Filing
Form 4 AMGEN INC For: Mar 16 Filed by: Santos Esteban
March 18, 2026 8:40 PM - SEC Filing
Form 4 AMGEN INC For: Mar 16 Filed by: REESE DAVID M
March 18, 2026 8:39 PM - SEC Filing
Form 4 AMGEN INC For: Mar 16 Filed by: Miller Derek
March 18, 2026 8:38 PM - SEC Filing
Form 4 AMGEN INC For: Mar 16 Filed by: Khosla Rachna
March 18, 2026 8:36 PM - SEC Filing
Form 4 AMGEN INC For: Mar 16 Filed by: Grygiel Nancy A.
March 18, 2026 8:34 PM - SEC Filing
Form 4 AMGEN INC For: Mar 16 Filed by: Griffith Peter H.
March 18, 2026 8:33 PM - SEC Filing
Form 4 AMGEN INC For: Mar 16 Filed by: Graham Jonathan P
March 18, 2026 8:31 PM - SEC Filing
Form 4 AMGEN INC For: Mar 16 Filed by: Gordon Murdo
March 18, 2026 8:30 PM - SEC Filing
Form 4 AMGEN INC For: Mar 16 Filed by: Bradway Robert A
March 18, 2026 8:29 PM - SEC Filing
Form 4 AMGEN INC For: Mar 16 Filed by: Busch Matthew C.
March 18, 2026 8:27 PM - SEC Filing
Jefferies Starts Vertex (VRTX) at Buy
March 10, 2026 5:37 AM - StreetInsider
Jefferies Starts Gilead Sciences (GILD) at Buy
March 10, 2026 5:37 AM - StreetInsider
Jefferies Starts Amgen (AMGN) at Hold
March 10, 2026 5:37 AM - StreetInsider
FDA: 'The agency today is withdrawing final guidance titled “Scientific Considerations in Demonstrating Biosimilarity to a Reference Product'
March 9, 2026 10:53 AM - StreetInsider
Full Article List
